Our recent studies demonstrated that induced expression of RNF144A decreases the sensitivity of breast cancer cells to poly(ADP‐ribose) polymerase (PARP) inhibitor olaparib through targeting DNA repair protein PARP1 for ubiquitination and subsequent proteasomal degradation6. The gene discussed is RNF144A; the disease is breast carcinoma.